Rocco Antonio Zoccali

ORCID: 0000-0002-9112-4580
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Obsessive-Compulsive Spectrum Disorders
  • Bipolar Disorder and Treatment
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Psychosomatic Disorders and Their Treatments
  • Treatment of Major Depression
  • Child and Adolescent Psychosocial and Emotional Development
  • Mental Health and Psychiatry
  • Attention Deficit Hyperactivity Disorder
  • Personality Disorders and Psychopathology
  • Maternal Mental Health During Pregnancy and Postpartum
  • Educational and Social Studies
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Eating Disorders and Behaviors
  • Sexuality, Behavior, and Technology
  • Epilepsy research and treatment
  • Impact of Technology on Adolescents
  • Healthcare professionals’ stress and burnout
  • Attachment and Relationship Dynamics
  • Electroconvulsive Therapy Studies
  • Personality Traits and Psychology
  • Gastrointestinal motility and disorders
  • Autism Spectrum Disorder Research
  • Systemic Sclerosis and Related Diseases
  • Pharmacological Effects of Natural Compounds

University of Messina
2013-2024

Policlinico Universitario di Catania
2010-2018

New York College of Podiatric Medicine
2017

Institute of Biomedical Science
2016

Don Carlo Gnocchi Foundation
2016

Creative Research Enterprises (United States)
2016

Peninsula Library System
2016

Center for Neurosciences
2015

Centro Neurolesi Bonino Pulejo
2011

We aimed to assess whether Internet addiction (IA) severity was related alexithymia scores among high school students, taking into account the role of gender differences and possible effect anxiety, depression, age. Participants in study were 600 students (ages ranging from 13 22; 48.16% girls) recruited three schools two cities Southern Italy. completed a sociodemographic questionnaire, Toronto Alexithymia Scale, Addiction Test, Hamilton Anxiety Depression Scale. The findings showed that IA...

10.1155/2014/504376 article EN cc-by The Scientific World JOURNAL 2014-01-01

Based on the evidence that aripiprazole added to serotonin reuptake inhibitors (SRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder (OCD) has reported promising results, present 16-week, double-blind, randomized, placebo-controlled trial had aim explore efficacy of add-on pharmacotherapy clinical symptoms and cognitive functioning a sample OCD patients receiving SRIs. After neurocognitive assessments, were randomly allocated receive, double-blind design, 15 mg/d...

10.1097/jcp.0b013e31820e3db6 article EN Journal of Clinical Psychopharmacology 2011-02-23

The present 16-week double-blind, randomized, placebo-controlled trial had the aim to explore efficacy of lamotrigine add-on pharmacotherapy on clinical symptomatology and cognitive functioning in a sample patients with treatment-resistant obsessive–compulsive disorder (OCD) receiving serotonin reuptake inhibitors (SRIs). After neurocognitive assessments, were randomly allocated receive, double-blind design, 100 mg/day or placebo. A final 33 completed study. results obtained indicate that...

10.1177/0269881111431751 article EN Journal of Psychopharmacology 2012-02-20

The development of therapeutic strategies to effectively treat negative symptoms remains one the primary goals in treatment schizophrenia. Mirtazapine is first a new class dual action compounds, noradrenergic and specific serotonergic antidepressants (NaSSa), whose activity related enhancement transmission by presynaptic alpha2 antagonism postsynaptic 5-HT2 5-HT3 antagonism, respectively. This study was 8-week double-blind, randomized, placebo-controlled trial 30 mg adjunctive mirtazapine...

10.1097/00004850-200403000-00003 article EN International Clinical Psychopharmacology 2004-02-18

The persistence of psychotic, affective, cognitive, and psychosocial symptoms despite medications is commonly observed in schizophrenic patients. present study was a 24-week double-blind, randomized, placebo-controlled trial aimed to explore the efficacy topiramate add-on pharmacotherapy on clinical symptomatology cognitive functioning sample treatment-resistant patients receiving clozapine. After assessments were randomly allocated receive either up 200 mg/day or placebo. A final 43...

10.1177/0269881110372548 article EN Journal of Psychopharmacology 2010-07-08

The aim of this study was to assess the risk exercise addiction (EA) in fitness clubs and identify possible factors development disorder. Exercise Addiction Inventory (EAI), Narcissistic Personality (NPI), Coopersmith Self-Esteem (SEI) were administered a sample 150 consecutive gym attenders recruited centers. Based on EAI total score, high EA group (HEA<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>51</mml:mn></mml:math>) low...

10.1155/2014/987841 article EN cc-by Journal of Addiction 2014-01-01

Among negative emotions, anger has not been studied in as much depth her connection to postpartum mood disorders. The study aimed investigate the role of a potential vulnerability factor increasing risk Maternity Blues (MB) and Postpartum Depression (PPD).Pregnant women their third trimester pregnancy underwent following tests: State Trait Anger Expression Inventory 2 - STAXI-2 (baseline visit), Questionnaire -BQ (3 5 days after delivery), Edinburgh Postnatal Scale (EPDS) 6 months...

10.1080/14767058.2017.1362554 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2017-08-01

Medical education is a time of high stress and anxiety for many graduate students in medical professions. In this study, we sought to investigate the effect academic on cortical excitability plasticity by using transcranial magnetic stimulation (TMS). We tested two groups (n = 13 each) healthy (mean age 33.7 ± 3.8 SE). One group was during final exam week (High-stress group) while other after break, without exams (Low-stress group). Students were required fill Perceived Stress Scale-10 (PSS)...

10.1080/10253890.2017.1301424 article EN Stress 2017-03-04

The effect of valproate on the steady-state plasma concentrations olanzapine was investigated in 18 patients with bipolar or schizoaffective disorder. Additional valproate, at a dose ranging from 600 to 2000 mg/d, administered for 4 weeks stabilized (5-20 mg/d). During coadministration, mean decreased significantly 32.9 ± 9.7 ng/mL baseline 27.4 9.8 week 2 (P = 0.02), and 26.9 9.2 0.001). Smoking also concentrations. Valproate coadministration well tolerated no patient showed worsening his...

10.1097/ftd.0b013e3181c0590e article EN Therapeutic Drug Monitoring 2009-12-01

Antidepressant drugs have often been used as an augmentation strategy for those patients who demonstrated a suboptimal response to clozapine. The present 16-week double-blind, randomized, placebo-controlled trial study aimed explore the efficacy and tolerability of duloxetine add-on pharmacotherapy on clinical symptomatology executive cognitive functioning in sample with treatment-resistant schizophrenia receiving After neurocognitive assessments, were randomly allocated receive,...

10.1097/yic.0b013e32834bbc0d article EN International Clinical Psychopharmacology 2011-10-04
Coming Soon ...